#1 Clinical Trials Search in Europe

Phenazone

This article explores the use of Antipyrine (also known as Phenazone) in clinical trials for two distinct medical conditions: ear pain associated with acute otitis media in children and asthma management in adults. Antipyrine is being studied both as a standalone treatment and in combination with other medications to assess its effectiveness in reducing pain and improving respiratory symptoms. These trials aim to provide valuable insights into potential new treatment options for patients suffering from these common ailments.

Table of Contents

What is PHENAZONE?

PHENAZONE, also known as Antipyrine, is a medication that belongs to a class of drugs called analgesics and antipyretics. These types of medications are used to relieve pain and reduce fever. PHENAZONE is often combined with other substances to create specialized treatments for various conditions[1].

Uses of PHENAZONE

PHENAZONE has several medical applications, including:

  • Ear Pain Relief: It is commonly used in combination with benzocaine (another pain-relieving medication) as an otic solution (ear drops) to treat pain associated with acute otitis media (middle ear infection) in children[1]. This condition causes pain and discomfort in the ear, which can be particularly distressing for young patients.
  • Asthma Management: Interestingly, there is ongoing research exploring the potential use of PHENAZONE in combination with benzocaine for managing moderate to severe asthma in adults[2]. This application is still experimental and not yet approved for general use.

How is PHENAZONE Administered?

The method of administration depends on the specific condition being treated:

  • For Ear Pain: PHENAZONE is typically administered as ear drops. In one study, a solution containing 54 mg of antipyrine (PHENAZONE) and 14 mg of benzocaine was used. The drops are applied along the wall of the ear canal until it’s filled, and this process is repeated every 3 hours for 24 hours, unless the patient is sleeping[1].
  • For Asthma (Experimental): In the ongoing asthma research, an otic solution (ear drops) containing antipyrine-benzocaine is being studied. The exact dosage and administration method for this use are still being determined[2].

Effectiveness of PHENAZONE

The effectiveness of PHENAZONE varies depending on its use:

  • For Ear Pain: Clinical trials have shown promising results in reducing pain associated with acute otitis media in children. The effectiveness is measured using pain scales such as the Face, Legs, Activity, Cry, Consolability (FLACC) scale for younger children and the Faces Pain Scale Revised (FPS-R) for older children[1].
  • For Asthma: The effectiveness of PHENAZONE in managing asthma is still being studied. Researchers hypothesize that by using a local anesthetic (like the PHENAZONE-benzocaine combination) to block certain nerves in the ear, it might improve various aspects of asthma, such as reducing the need for rescue inhalers and improving asthma treatment assessment scores[2].

Potential Side Effects

As with any medication, PHENAZONE may cause side effects. When used as ear drops, common side effects may include:

  • Stinging sensation in the ear
  • Burning feeling in the ear canal
  • Itching in the ear

It’s important to note that these side effects are generally mild and associated with topical use (application to the ear). Always consult your healthcare provider if you experience any unusual or severe side effects[2].

Ongoing Research

PHENAZONE is currently being studied for potential new applications:

  • Asthma Management: Researchers are investigating whether topical application of PHENAZONE combined with benzocaine in the ear canal can help reduce the need for rescue inhalers in adults with moderate to severe asthma. This study is still in its early stages, and more research is needed to determine its effectiveness and safety[2].

It’s important to remember that while this research is promising, PHENAZONE is not currently approved for asthma treatment. Patients should continue to follow their prescribed asthma management plan and consult with their healthcare provider before considering any new treatments.

Aspect Ear Pain Study Asthma Study
Condition Acute Otitis Media in children Moderate to severe asthma in adults
Antipyrine Formulation Otic solution (54 mg), alone or with Benzocaine (14 mg) Antipyrine-benzocaine otic solution
Primary Outcome Reduction in pain intensity at 1 hour after dosing Decrease in rescue inhaler usage over 4 weeks
Assessment Tools FLACC Scale (ages 2 months to 5 years), FPS-R (ages 5 to 12 years) Rescue inhaler usage, spirometry scores, ACT, ATAQ
Duration Up to 72 hours post first dose 4 weeks
Hypothesis Combination of Antipyrine and Benzocaine more effective than either alone or placebo Topical auricular anesthesia of vagus nerve decreases need for rescue inhalers

FAQ

  • What is Antipyrine (Phenazone) being studied for in these clinical trials? Antipyrine is being studied for two main purposes: 1) To relieve ear pain in children with acute otitis media, and 2) To potentially reduce the use of rescue inhalers in adults with moderate to severe asthma.
  • How is Antipyrine administered in these trials? In the ear pain study, Antipyrine is administered as an otic solution (ear drops), either alone or in combination with Benzocaine. For the asthma study, it's used as part of an otic solution applied to the ear canal to potentially affect the vagus nerve.
  • What are the main outcomes being measured in these trials? For the ear pain study, the main outcome is the reduction in pain intensity measured by specific pain scales. In the asthma study, the primary outcome is the decrease in usage of rescue inhalers over a four-week period.
  • Are there any side effects associated with Antipyrine use in these trials? The trials don't specifically mention side effects of Antipyrine. However, for topical anesthetics used in the ear (which may include Antipyrine), common side effects can include stinging, burning, or itching of the ear canal.
  • How long do these clinical trials last? The ear pain study measures outcomes up to 72 hours after the first dose. The asthma study lasts for four weeks for each participant.

Ongoing Clinical Trials on Phenazone

  • Study on the Effectiveness and Safety of AP707 and Naproxen for Patients with Chronic Back Pain

    Not recruiting

    1 1 1
    Investigated drugs:
    Austria Germany

Glossary

  • Acute Otitis Media: An infection of the middle ear that causes inflammation and pain, commonly occurring in children.
  • Antipyrine (Phenazone): A pain-relieving and fever-reducing medication being studied in these clinical trials for ear pain and asthma management.
  • Otic Solution: A liquid medication designed to be administered into the ear canal.
  • FLACC Scale: Face, Legs, Activity, Cry, Consolability Scale – a pain assessment tool used for young children who cannot verbalize their pain level.
  • FPS-R: Faces Pain Scale Revised – a pain assessment tool using facial expressions, typically used for older children.
  • Rescue Inhaler: A fast-acting inhaler used to quickly relieve asthma symptoms during an attack.
  • Spirometry: A common test used to assess how well your lungs work by measuring how much air you inhale and exhale.
  • Vagus Nerve: A major nerve that runs from the brain to the abdomen, playing a role in various bodily functions including breathing.
  • ACT: Asthma Control Test – a questionnaire used to measure asthma control in patients.
  • ATAQ: Asthma Therapy Assessment Questionnaire – another tool used to evaluate asthma control and management.

References

  1. https://clinicaltrials.gov/study/NCT02037893
  2. https://clinicaltrials.gov/study/NCT02153541